These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11989467)

  • 21. [Molecular cytogenetic monitoring of chimerism and minimal residual disease in patient with chronic myeloid leukemia after allogenic and syngenic bone marrow transplantation].
    Vinogradova OA; Savchenko VG; Domracheva EV; Liubimova LS; Ol'shanskaia IuV; Diachenko LV; Parovichnikova EN; Mendeleeva LP; Zakharova AV
    Ter Arkh; 2002; 74(7):38-44. PubMed ID: 12181833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen.
    Takami A; Chuhjo T; Nakao S
    Haematologica; 2002 Jun; 87(6):659-61. PubMed ID: 12031925
    [No Abstract]   [Full Text] [Related]  

  • 23. [Allogenic bone marrow transplantation in chronic myeloid leukemias].
    Liubimova LS; Savchenko VG; Mendeleeva LP; Kuz'mina LA; Anukhina MV; Gribanova EO; Demidova IA; Misiurin AV; Vinogradova OA; Domracheva EV; Poreshina LP; Kut'ina RM; Shpakova AP; Matveenko AA; Kalinin NN; Gemdzhian EG
    Ter Arkh; 2004; 76(7):18-24. PubMed ID: 15379122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.
    Eapen M; Giralt SA; Horowitz MM; Klein JP; Wagner JE; Zhang MJ; Tallman MS; Marks DI; Camitta BM; Champlin RE; Ringdén O; Bredeson CN; Martino R; Gale RP; Cairo MS; Litzow MR; deLima M
    Bone Marrow Transplant; 2004 Oct; 34(8):721-7. PubMed ID: 15322568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
    Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
    Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of imatinib in the treatment of acute lymphoid leukemias].
    Poros A; Lovas N
    Orv Hetil; 2005 May; 146(18 Suppl 1):905-10. PubMed ID: 15921303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor cell-derived myelodysplastic syndrome in a patient 7 years after unrelated allogeneic HLA-mismatched transplantation for Ph+ chronic myeloid leukemia.
    Kraut L; Trebeljahr G; Thiele B; Fauser AA
    Bone Marrow Transplant; 2005 Oct; 36(8):737. PubMed ID: 16086042
    [No Abstract]   [Full Text] [Related]  

  • 28. One survivor's tale: notes from the edge.
    Landro L
    Oncologist; 1999; 4(1):64-9. PubMed ID: 10337373
    [No Abstract]   [Full Text] [Related]  

  • 29. Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Sekhri A; Liu D; Rasul M; Ahmed N; Ahmed T; Seiter K
    Leuk Res; 2009 Sep; 33(9):1291-3. PubMed ID: 19344950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The leukemias.
    Preisler HD
    Dis Mon; 1994 Oct; 40(10):525-79. PubMed ID: 7924833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful application of epidermal growth factor for treatment of hemorrhagic cystitis after bone marrow transplantation.
    Dorticós E; Pavón V; Jaime JC; Reboredo M; López Saura P; Berlanga J; Hernández P
    Bone Marrow Transplant; 2003 Apr; 31(7):615-6. PubMed ID: 12692631
    [No Abstract]   [Full Text] [Related]  

  • 32. [Allogenic bone marrow transplantation in acute leukemias and chronic myeloid leukemia].
    Mendeleeva LP
    Ter Arkh; 2003; 75(7):89-94. PubMed ID: 12934492
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chronic myeloid leukemia--treatment].
    Stoetzer OJ; Hentrich M; Salat C
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2621-4. PubMed ID: 12469275
    [No Abstract]   [Full Text] [Related]  

  • 34. Imatinib resistant chronic myelogenous leukemia, BCR-ABL positive by chromosome and FISH analyses but negative by PCR, in a child progressing to acute basophilic leukemia: cytogenetic follow-up.
    Moser AM; Manor E; Narkis G; Kapelushnik J
    Cancer Genet Cytogenet; 2006 Oct; 170(1):54-7. PubMed ID: 16965955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone-marrow transplantation.
    Magrath I
    Lancet; 1995 Jul; 346(8966):59-60. PubMed ID: 7603173
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation.
    Weisser M; Tischer J; Schnittger S; Schoch C; Ledderose G; Kolb HJ
    Haematologica; 2006 May; 91(5):663-6. PubMed ID: 16627251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing of allogeneic BMT for CML patients in India: does it affect response?
    Sazawal S; Hasan SK; Kumar B; Kumar R; Kumar L; Saxena R
    Am J Hematol; 2007 Apr; 82(4):329. PubMed ID: 16947319
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of chronic myelogenous leukemia with imatinib mesylate resulting in hematological remission and marked regression of myelofibrosis].
    Takahari D; Matsunaga T; Fujimi A; Kikuchi T; Seki R; Tanaka I; Takemoto N; Akiyama T; Sato T; Terui T; Kogawa K; Kato J; Kura T; Maeda T; Niitsu Y
    Rinsho Ketsueki; 2002 Oct; 43(10):924-30. PubMed ID: 12462028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of late CML relapse.
    Flowers M
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):847-8. PubMed ID: 18541206
    [No Abstract]   [Full Text] [Related]  

  • 40. Monitoring of minimal residual disease after allografting: a requirement to guide DLI treatment?
    Dazzi F
    Ann Hematol; 2002; 81 Suppl 2():S29-30. PubMed ID: 12611066
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.